Explore

U.S. Officials Address Research Gaps in Menopause Care, Including Testosterone Use

U.S. Officials Address Research Gaps in Menopause Care, Including Testosterone Use

U.S. officials, including Dr. Dorothy Fink, deputy director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, are calling for more specific research into menopause care, particularly concerning the use of testosterone to treat symptoms. This comes as testosterone is increasingly promoted on social media as a 'cure-all' for menopause symptoms, despite a lack of solid scientific backing for its widespread use. The debate over testosterone is occurring against a backdrop of menopausal hormone therapy moving mainstream after years of declining use due to past methodological flaws in studies that skewed perceived risks. While the Journal of Obstetrics and Gynaecology issued a guideline in 2021 affirming menopausal hormone therapy as the 'most effective option' for symptoms like hot flashes for most women under 60 or less than 10 years post-menopause, the scientific community emphasizes the need for evidence-based approaches, especially for newer treatments like testosterone...

Novo Nordisk Advances Connected Drug Delivery with Smart Insulin Pens

Novo Nordisk Advances Connected Drug Delivery with Smart Insulin Pens

Novo Nordisk, a global healthcare company headquartered in Denmark, is actively participating in the connected drug delivery devices market. The company offers smart insulin pens, specifically NovoPen 6 and NovoPen Echo Plus, which are designed to record injection time and dose information. This data is then transferred to compatible diabetes applications, providing users with a comprehensive overview of their insulin administration and treatment tracking. Furthermore, Novo Nordisk has collaborated with BIOCORP on Mallya, a smart add-on device for the FlexTouch insulin pen. This partnership aims to enhance connected injection capabilities and reinforce Novo Nordisk's commitment to digitally enabled insulin delivery solutions for individuals managing diabetes.

Richmond Advocates March for Nursing Home Reform and Accountability

Richmond Advocates March for Nursing Home Reform and Accountability

Richmond advocates gathered on Sunday to demand reform in long-term care facilities, citing concerns over neglect and lack of accountability for harm to residents. Tracy Pompey, founder of Justice and Change for Victims of Nursing Facilities, organized a 'ROAR Walk' in Richmond, which stands for Respect, Advocacy, Oversight, and Reform. This event is part of a broader national effort with similar walks occurring in various states. Pompey's personal motivation stems from the loss of her father in 2015 due to what she describes as nursing facility neglect, for which she found no accountability. Advocates highlight that Virginia is among the five worst states nationally for nursing home staffing, a factor they believe directly impacts the quality of care residents receive. Families have reported significant delays, sometimes hours long, in receiving basic needs such as bathing or assistance with using the bathroom. While acknowledging that Virginia has begun implementing changes, advocates stress that more wo...

U.S. Government Underestimates Number of Thalidomide Survivors, Advocacy Group Claims

U.S. Government Underestimates Number of Thalidomide Survivors, Advocacy Group Claims

A new report suggests that the U.S. government significantly underestimates the number of thalidomide survivors in the country. While the Food and Drug Administration (FDA) formally acknowledges only 17 American-born babies affected by the drug, Jennifer Vanderbes, author of 'Wonder Drug,' estimates there could be around a hundred U.S. survivors. Thalidomide, a sedative, was not approved for general use in the U.S. due to the persistence of Dr. Frances Oldham Kelsey, an FDA pharmacologist. However, the Cincinnati-based pharmaceutical company William S. Merrell distributed thousands of unlabeled doses to doctors for an unregulated clinical trial in the early 1960s, without requiring tracking or side effect reports. Many pregnant women were unknowingly given the drug, leading to children being born with severe limb deformities, known as phocomelia. Doctors often failed to document the drug's use or inform patients, and years later, many survivors were told thalidomide did not affect the U.S. Gwen Riechmann, ...

Pharmacogenomic Testing Advances Personalized Medicine in the U.S. Healthcare System

Pharmacogenomic Testing Advances Personalized Medicine in the U.S. Healthcare System

Pharmacogenomic testing is emerging as a crucial tool in personalized medicine within the U.S. healthcare landscape. This testing involves analyzing a patient's genetic makeup to predict their response to various medications. By examining genetic variations that influence drug metabolism, efficacy, and safety, healthcare providers can gain insights to guide treatment decisions. The goal is to optimize drug therapy and minimize adverse drug reactions, moving away from a one-size-fits-all approach to medication. This field is rapidly evolving due to advancements in genetic sequencing and analysis technologies, drawing significant attention from the healthcare community. The insights derived from these tests enable more informed decision-making regarding drug prescriptions, allowing providers to select medications that are most effective and least hazardous for individual patients based on their unique genetic profiles.

Rockland Chiropractic, P.C. Emphasizes Holistic Chiropractic Wellness in Suffern, NY

Rockland Chiropractic, P.C. Emphasizes Holistic Chiropractic Wellness in Suffern, NY

Rockland Chiropractic, P.C. in Suffern, NY, led by Dr. Kenneth Blank, is dedicated to promoting chiropractic wellness through a holistic approach. The practice aims to help individuals achieve optimal health by ensuring balance and alignment, thereby enhancing the body's natural healing capabilities. Chiropractic care, meaning 'done by hand,' is presented as a natural, drug-free healing art. Dr. Blank and his team integrate the latest applications and technology for injury rehabilitation and biomechanical improvements, focusing on utilizing the body's inherent ability to heal. The mission of Rockland Chiropractic, P.C. is to empower people to realize that health and energy originate from within, advocating for the maintenance of health over the treatment of disease for a balanced lifestyle. This approach highlights the importance of adapting to physical, chemical, and emotional stressors to maintain well-being.

Surgery Partners' Idaho Falls Sale Reshapes Investment Outlook and Capital Structure

Surgery Partners' Idaho Falls Sale Reshapes Investment Outlook and Capital Structure

Surgery Partners' Idaho Falls Sale Reshapes Investment Outlook and Capital Structure

La Vie Mind Longevity Clinic Opens in Austin, Texas, Focusing on Cognitive Enhancement

La Vie Mind Longevity Clinic Opens in Austin, Texas, Focusing on Cognitive Enhancement

La Vie Mind Longevity Clinic Opens in Austin, Texas, Focusing on Cognitive Enhancement

Nationwide Seeks Senior Living Risk Management Consultant to Enhance Safety and Mitigate Liability

Nationwide Seeks Senior Living Risk Management Consultant to Enhance Safety and Mitigate Liability

Nationwide Seeks Senior Living Risk Management Consultant to Enhance Safety and Mitigate Liability

Regulatory Frameworks Lag Behind Adaptive Platform Trials in Drug Development

Regulatory Frameworks Lag Behind Adaptive Platform Trials in Drug Development

The field of infectious disease research has seen significant advancements with the implementation of adaptive platform trials, such as REMAP-CAP and RECOVERY, particularly during the COVID-19 pandemic. These trials, which can continuously evolve by adding or removing treatment arms based on accumulating evidence, have demonstrated the ability to generate robust efficacy signals at an unprecedented speed. For instance, REMAP-CAP enrolled nearly 5,000 critically ill COVID-19 patients across 25 countries, and its broader sub-study included over 9,000 participants, allowing for rapid evaluation of various interventions like immunoglobulin therapy and corticosteroid dosing. The RECOVERY trial, utilizing NHS infrastructure, similarly identified the effectiveness of casirivimab and imdevimab in reducing mortality for hospitalized COVID-19 patients. Despite the proven scientific and operational efficacy of these dynamic trial designs, current regulatory frameworks, including the FDA's 2023 draft guidance on Maste...

Pharmacogenomic Testing Offers Personalized Approach to Antidepressant Treatment for Teens

Pharmacogenomic Testing Offers Personalized Approach to Antidepressant Treatment for Teens

Pharmacogenomic (PGx) testing is emerging as a tool to personalize antidepressant treatment, particularly for teenagers who may not respond to initial medications. This testing analyzes an individual's genetic makeup to predict how their body processes certain drugs. Specifically, in mental health, panels often focus on liver enzymes like CYP2D6 and CYP2C19. Variations in these genes can classify a person as a poor, intermediate, normal, rapid, or ultrarapid metabolizer of a given drug. For instance, a poor metabolizer might experience higher drug levels and more side effects from a standard dose, while an ultrarapid metabolizer might clear the medication too quickly for it to be effective. The process involves a cheek swab, with results typically available to the prescriber within about three days. While the FDA acknowledges gene-drug links in some medications, it also notes that genetic makeup is just one of many factors influencing drug response. Test manufacturers emphasize that results do not diagnose...

Novo Nordisk Licenses Nanexa's PharmaShell Technology for Long-Acting GLP-1 Treatments

Novo Nordisk Licenses Nanexa's PharmaShell Technology for Long-Acting GLP-1 Treatments

Novo Nordisk Licenses Nanexa's PharmaShell Technology for Long-Acting GLP-1 Treatments